|
Volumn 33, Issue 4, 2001, Pages 963-971
|
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B(E) ANTIGEN;
HLA A2 ANTIGEN;
LAMIVUDINE;
ADULT;
ARTICLE;
CHRONIC HEPATITIS;
CLINICAL ARTICLE;
CYTOTOXIC T LYMPHOCYTE;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
IMMUNOTHERAPY;
MALE;
PERSISTENT VIRUS INFECTION;
PRIORITY JOURNAL;
T LYMPHOCYTE;
VIRUS LOAD;
VIRUS REPLICATION;
|
EID: 17744383748
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2001.23045 Document Type: Article |
Times cited : (330)
|
References (22)
|